Director of Biomarker, Translational Medicine
Company: Mitsubishi Tanabe Pharma
Location: Jersey City
Posted on: June 4, 2021
Spirit, Rooted in Tradition. At Mitsubishi
Tanabe Pharma Development America, Inc. (MTDA), we can tout a
storied reputation more than 300 years in the making. Our parent
company, Mitsubishi Tanabe Pharma Corporation (MTPC), is a
research-driven pharmaceutical company with global reach – and one
of Japan’s oldest and most respected companies.
MTDA is rapidly
expanding our operation across all functional areas to assist in
the research and development of new products for the U.S.
The Director of
Biomarker, Translational Medicine (TM), will be primarily
responsible for creating and implementing program translational
plans that are aligned with company’s disease and pathway
strategies. The successful candidate will be responsible for
shaping the strategic vision for programs and in creating and
implementing experimental medicine studies. This role will partner
with translational research to engage in external interactions with
academic institutions having strong capabilities in translational
studies and with external scientific experts.
the Senior Director of the Translational Medicine group, the
Director of Biomarker, TM will lead clinical and scientific aspects
of translational studies from Phase 0 through Proof-of-Concept
(PoC) studies. In this role, the Director, TM, will contribute to
accelerating the company’s pipeline from portfolio entry to
Translational Medicine group serves as a pivotal bridge between
Discovery/Translational Research and the later phase Clinical
Development group. It provides the necessary scientific and
clinical expertise to advance an industry-leading pipeline of novel
mechanism small molecules and biologic agents to address unmet need
in immunology, neurology, and other rare diseases. This position
will play a ‘dual role’, contributing both scientific and clinical
development expertise to TM projects.
with colleagues from Mitsubishi Tanabe Pharma Development America
(MTDA) and Mitsubishi Tanabe Pharma Corporation (MTPC, Japan) to
support research and product development activities, including
evaluation of target indications, support the development of target
executes biomarker strategy for all stages of MTDA development
the design and execution of translational strategies, integrating
both disease and pathway approaches.
with translational research on the development and implementation
of clinical biomarker and patient segmentation
design and execution of early clinical trials through PoC including
experimental medicine studies.
on early and late development teams.
among project team when presenting to portfolio, project and
collaborates with academic translational sites to optimize the
translational strategy and plans for programs.
directs the preparation and review of study protocols, clinical
study reports and translational medicine sections of Translational
plans, IBs, INDs, abstracts, manuscripts, and technical
presentation of results and updates of projects at department,
project, corporate and scientific meetings.
- Advanced Degree
in Life Sciences (MD, PhD, Pharm D, or MD/PhD) is
- Minimum of 7
years of industry experience (Pharmaceutical, Biotech, or related
field). Minimum of 5 years in translational medicine or
translational research in industry.
experience and proven expertise in biomarker development and
precision medicine. Experience in one or more of other TM areas,
e.g., early stage clinical development and disease biology
research, is a plus.
competence in clinical therapeutics, drug development, business and
market knowledge, and strategic resource management.
knowledge in immunology, neurology and rare diseases is strongly
understanding of the FDA, and ethical guidelines relevant to the
- Able to rapidly
learn new therapeutic areas in a self-taught and peer-to-peer team
communications skill set: verbal, written, and presentation must be
of outstanding quality and clarity. Native, or near native-level
English language proficiency is required, with additional secondary
language skills (in particular, Japanese language is a
interpersonal skill set: must possess the ability to interact
amicably and professionally with all individuals at all levels of
skill and experience, and across worldwide cultures, within the
universe of pharmaceutical development. Must be capable of
networking to discover and utilize resources critical to job
performance and success.
enthusiastic team player with excellent collaboration and teamwork
analytical and evaluative skills.
- Able to
organize, prioritize, and work effectively in a constantly changing
- Ability to
interface effectively with a variety of technical platforms for the
collection, review, and dissemination of medical
knowledge of MS Office (Word, PowerPoint, Excel).
- Required to
travel up to 30% of the time (domestic and international), or as
fast-moving, entrepreneurial spirit more typically found in a small
biotech, complemented by the benefits of a global
pharmaceutical/chemical conglomerate. At this time, MTDA offers our
employees outstanding opportunities for career success coupled with
a supportive level of employee benefits:
| Life Insurance | Supplemental Life Insurance/Dependent Life
Insurance | Accidental Death & Dismemberment Insurance | Business
Travel Accident Insurance | Short-Term Disability | Long-Term
Disability | Flexible Spending Accounts | Employee’s Savings Plan
(401K Plan) | Competitive Paid Time Off
Keywords: Mitsubishi Tanabe Pharma, Jersey City , Director of Biomarker, Translational Medicine, Other , Jersey City, New Jersey
Didn't find what you're looking for? Search again!